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Bronchial epithelial cells play a pivotal role in airway inflammation, but little is known about posttran-
scriptional regulation of mediator gene expression during the inflammatory response in these cells. Here, we
show that activation of human bronchial epithelial BEAS-2B cells by proinflammatory cytokines interleukin-4
(IL-4) and tumor necrosis factor alpha (TNF-) leads to an increase in the mRNA stability of the key
chemokines monocyte chemotactic protein 1 and IL-8, an elevation of the global translation rate, an increase
in the levels of several proteins critical for translation, and a reduction of microRNA-mediated translational
repression. Moreover, using the BEAS-2B cell system and a mouse model, we found that RNA processing
bodies (P bodies), cytoplasmic domains linked to storage and/or degradation of translationally silenced
mRNAs, are significantly reduced in activated bronchial epithelial cells, suggesting a physiological role for P
bodies in airway inflammation. Our study reveals an orchestrated change among posttranscriptional mecha-
nisms, which help sustain high levels of inflammatory mediator production in bronchial epithelium during the
pathogenesis of inflammatory airway diseases.
Persistent inflammation of the respiratory tract in chronic
pulmonary disease is mediated by increased expression of mul-
tiple inflammatory mediators (reviewed, e.g., in references 3
and 4). During allergic airway inflammation, the Th2 cell-
associated cytokines (e.g., interleukin-4 [IL-4] and IL-13)
strongly synergize with other proinflammatory cytokines, such
as tumor necrosis factor alpha (TNF-), to stimulate produc-
tion of eosinophil- and Th2-specific chemokines in epithelial
cells, endothelial cells, and tissue macrophages (2, 3, 67). As
chemokines help shape the manner by which the immune sys-
tem responds to inflammatory stimuli (59), increased chemo-
kine expression could sustain an inflammatory reaction well
beyond its original purpose, thereby leading to chronic inflam-
mation (reviewed in, e.g., references 23 and 59).
The bronchial airway epithelium is directly exposed to the
environment and is the first line of defense against airborne
particulate matter, allergens, and infectious agents; it plays a
critical role not only in the maintenance of physicochemical
homoeostasis of the airways but also in the pathogenesis of
airway diseases. During allergic airway inflammation the epi-
thelium is both a source of mediator production as well as a
target of remodeling processes (31, 61). Recent findings fur-
ther support the view that the epithelium also plays a central
role in the Th2 cell sensitization process by influencing the
function of antigen-presenting dendritic cells in the airways
(for recent reviews, see references 3 and 61). Thus, under-
standing the biochemical and molecular basis on which the
expression of inflammatory mediators is regulated in the bron-
chial epithelium will provide important new insight into in-
flammatory airway diseases and identify novel therapeutic tar-
gets.
Previous studies have revealed a wealth of knowledge about
the complex transcriptional programs that regulate the expres-
sion of genes coding for various mediators of inflammation (13,
28, 30, 56). However, relatively little is known about the mech-
anisms controlling the expression of these genes at posttran-
scriptional levels in inflammation. In this study we used the
human bronchial epithelial BEAS-2B cell line stimulated with
proinflammatory cytokines IL-4 and TNF- as a cellular model
to investigate gene regulation at the level of mRNA turnover
and translation in activated bronchial epithelial cells. Previ-
ously, it was shown that the stability of a chemokine mRNA
coding for eotaxin-1 (or CCL11) in BEAS-2B cells increased
when the cells were treated with both IL-4 and TNF- (2),
suggesting the feasibility of using this in vitro cellular model
system to study gene regulation relevant to airway inflamma-
tion. This approach is further substantiated by our current
genome-wide microarray analysis. Using this system, we found
that both mRNA and protein levels of key chemokines such as
monocyte chemotactic protein 1 (MCP-1) and IL-8 increased
upon stimulation of BEAS-2B cells and that their mRNAs
were more stable in the activated cells. In addition, an en-
hancement of the global translation rate in activated bronchial
epithelial cells was observed. Moreover, our data show that
IL-4/TNF- stimulation of BEAS-2B cells led to an elevation
of the level of translation factors critical for enhancing trans-
lation efficiency accompanied by a reduction of the transla-
tional silencing mediated by microRNAs (miRNA). This group
of evolutionarily conserved and abundant small noncoding
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RNAs downregulate gene expression across species and in
multiple biological processes through base-pairing to the 3
untranslated regions (UTRs) of target mRNAs (reviewed in,
e.g., references 21 and 34).
Recently, a newly identified cytoplasmic domain, termed
RNA processing body (P body), was found to be a site for
storage and/or degradation of translationally silenced mRNAs
including miRNA-silenced mRNPs (17, 37, 49). Using both the
BEAS-2B cell model and an in vivo mouse model of allergic
airway inflammation, we show that P-body formation is signif-
icantly reduced in activated bronchial epithelial cells. These
observations are consistent with our data showing that mRNA
degradation and translational repression are compromised
during allergic airway inflammation. To our knowledge, this
finding represents the first demonstration of a physiologically
relevant regulation of mammalian P bodies observed in vivo.
Collectively, this study reveals a dynamic linkage among post-
transcriptional mechanisms that facilitate and fine-tune a cell’s
response to external influences.
MATERIALS AND METHODS
Plasmids. To construct the plasmids pTet-BBBARE(IL-8) (where Tet is
tetracycline and BBB is -globin) and pTet-BBBARE(MCP-1), AU-rich ele-
ment (ARE) sequences of IL-8 and MCP-1 were amplified by PCR using
genomic DNA extracted from BEAS-2B cells as a template and then cloned into
the unique BglII site of plasmid pTet-BBB (11). The IL-8 ARE sequence is from
positions 998 to 1199 in human IL-8 cDNA (NM_000584), and the MCP-1
(CCL2) ARE sequence is from positions 441 to 653 in human CCL2
(NM_002982). Construction of plasmid pSV1/GAPDH (where GAPDH is glyc-
eraldehyde-3-phosphate dehydrogenase) has been described previously (8). Plas-
mids expressing Renilla luciferase mRNA and its derivatives carrying three let-7
miRNA target sites, three mutated nonfunctional let-7 target sites, or a single
site that forms a perfect match with let-7 miRNAs (54) were kindly provided by
W. Filipowicz and are referred to here as RL, RL(let-7wt), RL(let-7mut), and
RL(let-7per), respectively. To create RLmiR-29a and RLmiR-155, sequences
encoding three copies of the miR-155 or miR-29a target site (searched by
miRBase and TargetScan) were synthesized and inserted between the XbaI and
NotI sites of the Renilla luciferase reporter gene.
Cell culture and transfection. The human bronchial epithelial BEAS-2B cell
line was purchased from ATCC and cultured in F12-Dulbecco’s modified Eagle’s
medium containing heat-inactivated fetal calf serum (5%), L-glutamine (2 mM),
penicillin (100 g/ml), and streptomycin (100 mg/ml). For IL-4/TNF- stimula-
tion, cells were cultured for 18 h in medium containing 50 ng/ml of each cytokine.
For transient transfection experiments, a tTA-expressing BEAS-2B-19 stable
cell line (12) that supports transcription of genes driven by the Tet-off or Tet-on
promoter was first seeded in six-well plates at a density of 0.25  106 to 0.3  106
cells per well for 1 day and then transfected with pTet-BBB or pTet-BBBARE
plasmids with a control plasmid, pSV1/GAPDH (8), using FuGENE 6 (Roche).
Time course experiments using the Tet-off system for transcriptional pulsing and
Northern blot analysis to determine mRNA stability were performed as de-
scribed previously (12).
RNA extraction and analysis. Total RNA was extracted using Trizol (Invitro-
gen) or RNeasy Mini Kit (Qiagen) following the manufacturer’s protocols. For
real-time quantitative reverse transcription-PCR (RT-PCR), 250 to 500 ng of
RNA was used in a 10-l RT reaction mixture containing 1 unit of SuperScript
II reverse transcriptase (Invitrogen). The reaction was incubated at 50°C for 30
min, followed by heat inactivation at 72°C for 5 min. After RT, PCRs containing
a 1:20,000 dilution of Sybr Green (Cambrex Bio Science Rockland, Inc.) and 0.1
U/l JumpStart Taq DNA polymerase (Sigma-Aldrich) were performed accord-
ing to the manufacturer’s protocol (Eppendorf) using an Eppendorf Mastercy-
cler ep realplex quantitative PCR machine. The reactions were performed as
follows: 94°C for 2 min; 35 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 1
min; followed by 72°C for 5 min and a default melting curve programmed by the
instrument.
Analyses of polysome profiles by sucrose gradient fractionation were per-
formed as described previously (9). Briefly, cytoplasmic lysates prepared from
approximately 5  107 nonstimulated or IL-4/TNF- stimulated BEAS-2B cells
were overlaid on a continuous sucrose gradient (15% to 40%). The gradient was
centrifuged using a Beckman SW41 rotor at 38,000 rpm for 2 h with medium
acceleration and no brake. Immediately after centrifugation, 500-l aliquots
were taken from top to bottom of the gradient, with 20 aliquots prepared in total.
RNA was extracted from each fraction and used for electrophoresis in 1%
agarose to visualize the distributions of 5.5S, 18S, and 28S rRNA bands.
Illumina microarrays. Triplicate samples of total cytoplasmic mRNA were
prepared from nonstimulated or IL-4/TNF--stimulated BEAS-2B cells. RNA
amplification and microarray hybridization were carried out in the Microarray
Core Laboratory at the University of Texas Health Science Center (Houston,
TX) using Illumina Genome-Wide Expression BeadChips (Human Ref-6 v1;
Illumina Inc.), representing43,000 human transcripts (40). Two hundred nano-
grams of total RNA was reverse transcribed and amplified overnight with T7
RNA polymerase and labeled with biotin following the manufacturer’s protocol.
Biotin-labeled amplified RNA (1.5g) was hybridized to the microarrays at 58°C
overnight. Arrays were incubated with Cy3-streptavidin and washed according to
the manufacturer’s instructions. Initial analysis of the microarray data was done
using Illumina’s Beadstudio, version 3. After background subtraction, arrays
were normalized to each other by rank-invariant normalization. Changes in gene
expression were tested using a modified t test, which employs estimates of
variation that include sequence-specific biological variation (bio), nonspecific
biological variation (neg), and technical error (tech) as described in the user’s
guide (Illumina Inc.).
Western blot analysis. Cytoplasmic or total lysates were prepared as described
previously (52). Cell lysates (5 to 40 g) were resolved on an 8% or 15% sodium
dodecyl sulfate-polyacrylamide gel and analyzed using an ECL Western blotting
kit (Bio-Rad). The polyvinylidene difluoride blots were probed with specific
antibodies as indicated in each figure and detected with SuperSignal West Pico
Chemiluminescent Substrate (Pierce). Membranes were incubated with one of
the primary antibodies at the following dilutions: anti-eukaryotic initiation factor
4E (eIF4E) (Cell Signaling Technology) at 1:500, anti-4E binding protein 1
(4E-BP1) phosphorylated at Ser 65 (Cell Signaling Technology) at 1: 2,000,
anti-termination release factor 1 (eRF1; Abcam) at 1:500, anti-poly(A)-binding
protein (PABP; a gift from R. Lloyd) at 1:3,000, anti-Dcp1a (a gift from S. Ohno)
at 1:4,000, anti-Rck/p54 (Bethyl) at 1:3,000, and anti--tubulin monoclonal an-
tibody (Sigma) at 1:10,000. The fluorescence signals and intensity of detected
bands were captured and quantified by an imaging system (Syngene) and the
software GeneTools (Syngene), respectively.
Global translational rate measurement. To pulse label proteins with [35S]me-
thionine in BEAS-2B cells, 0.43  106 cells were first seeded in each 6-cm plate.
Twenty-four hours later, cells were either left untreated or stimulated by IL-4/
TNF- for 18 h. Both nonstimulated and stimulated cells were incubated for 1 h
with 2 ml of Gibco’s methionine- and cysteine-free Dulbecco’s modified Eagle’s
medium containing fetal bovine serum (also containing IL-4/TNF- for stimu-
lated cells). The medium was then replaced with fresh medium containing 100
Ci of 35S labeling mix (Perkin Elmer). After 0, 30, and 60 min of labeling, cells
were harvested and lysed for trichloroacetic acid precipitation to quantitate
incorporation of [35S]methionine and cysteine. The experiment was performed in
triplicate.
Quantification of cytokine and chemokine proteins. Equivalent numbers of
BEAS-2B cells without or with IL-4/TNF- stimulation were lysed in cytoplasmic
lysis buffer (10 mM HEPES [pH 7.6], 3 mM MgCl2, 40 mM KCl, 5% glycerol,
0.5% NP-40, 1 protease inhibitor cocktail, 1 mM dithiothreitol), and nuclei
were removed by centrifugation. The protein concentration of the supernatant
(cytoplasmic lysate) was adjusted to 0.5 mg/ml. Fifty microliters of each cyto-
plasmic lysate was used for cytokine and chemokine detection and quantification
by a Quantibody Human Inflammation Array I kit (RayBiotech, Inc.) according
to the manufacturer’s protocol. The signals (green fluorescence, Cy3 channel,
555-nm excitation, and 565-nm emission) were captured using an Axon GenePix
laser scanner (the Microarray Core Laboratory at the University of Texas Health
Science Center, Houston, TX). Quantitative data analysis was performed using
RayBio Q Analyzer software (RayBiotech, Inc.).
Renilla and firefly dual luciferase assay. BEAS-2B cells were seeded (0.3 106
cells/6-cm plate) 24 h before transfection. For each plate, 0.02 ng of Renilla
luciferase plasmid, 4 ng of firefly luciferase plasmid (pUHC13), and 2.2 g of
pT18 plasmid were transfected using FuGENE 6 transfection reagent (Roche)
following the manufacturer’s instructions. The next day, half of the plates were
stimulated by 50 ng/ml TNF-/IL-4 for 18 h. Both nonstimulated and stimulated
samples were harvested 42 h after transfection. The pellet was prepared for
luciferase assay using a Dual-Luciferase Reporter Assay System (Promega) ac-
cording to the manufacturer’s protocol.
Immunofluorescence microscopy. BEAS-2B cells in slide chambers were fixed
with 3.7% paraformaldehyde and permeabilized with methanol and 0.5% Triton
X-100. Following incubation with rabbit anti-human Dcp1a antibody (1:500
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dilution), fluorescent donkey anti-rabbit antibody, coupled to Alexa 555 (Invitro-
gen) was used for secondary detection at 1:1,000 dilution. Fluorescent mounting
medium containing DAPI (4,6-diamidino-2-phenylindole) was applied to the
slides before the placement of coverslip and microscopy. Images were obtained
at room temperature by optical z-sectioning (20 sections in total with a 0.2-m
space between sections) using an Olympus objective lens (100 with a numerical
aperture of 1.35) of a DeltaVision deconvolution microscope system containing
an Olympus IX70 inverted microscope.
Ovalbumin sensitization and challenge. Six-week old BALB/c female mice
were sensitized by an intraperitoneal injection of 500 l of solution containing 8
mg/ml ovalbumin (Sigma-Aldrich) and 8 mg/ml alum (Sigma-Aldrich) on days 0,
7, and 14 (75). Mice were challenged intranasally with 30 ml of saline or ovalbu-
min (8 mg/ml) on days 14, 21, 22, and 23 and were sacrificed 24 h after the last
installation. The lungs were processed for analysis of lavage cellularity and then
infused with 10% buffered formalin and processed for paraffin embedding.
Dcp1a and MCP-1 immunodetection in mouse bronchial epithelium. Lung
sections (5 m) were deparaffinized and processed for Dcp1a immunofluores-
cence. Sections were blocked in 1% bovine serum albumin and incubated for 1 h
at room temperature with a 1:500 dilution of rabbit anti-human Dcp1a antibody.
This was followed by incubation with a 1:1,000 dilution of donkey anti-rabbit
secondary antibody coupled to Alexa 555 (Invitrogen). Coverslips were mounted
using mounting medium containing DAPI to visualize nuclei. Quantitation of P
bodies was determined by counting the number of bronchial epithelial cells per
millimeter of airway basement membrane that contained 20 or more P bodies
(P-body index) using ImagePro Plus software (Media Cybernetics). At least three
airways from each of four different mice per group were analyzed.
For MCP-1 immunoperoxidase detection, 5-m lung sections were deparaf-
finized and quenched with 0.5% hydrogen peroxide, and antigen retrieval was
performed (Dako). Slides were then incubated overnight at 4°C with a 1:600
dilution of goat anti-mouse MCP-1 antibody (R&D Systems). A rabbit anti-goat
Elite detection system (Vector Laboratories) was used in conjunction with 3,3-
diaminobenzidine peroxidase detection (Sigma) and counterstaining with methyl
green.
Microarray data accession number. The raw microarray data without normal-
ization has been deposited in the Gene Expression Omnibus database (http:
//www.ncbi.nlm.nih.gov/projects/geo/) under accession number GSE13119.
RESULTS
BEAS-2B cell model for the study of posttranscriptional
regulation of genes related to airway inflammation. We first
tested whether IL-4, a Th2 cell-associated cytokine, and
TNF-, a key proinflammatory cytokine, act synergistically in
BEAS-2B cells to upregulate genes preferentially expressed
during Th2 responses. We examined the level of the mRNA
encoding a key chemokine, MCP-1 (42, 47), in cells treated
with either IL-4 or TNF- alone or with both. The results of
real-time RT-PCR quantification show that treatment with
either IL-4 or TNF- alone increases MCP-1 mRNA to a level
only 35% of that produced by treatment with both TNF- and
IL-4 together (Fig. 1A). Importantly, while the 18-h treatment
with both IL-4 and TNF- activates BEAS-2B cells effectively,
it does not produce any significant apoptosis of the cells (data
not shown).
The changes in mRNA level in BEAS-2B cells upon 18-h
IL-4/TNF- stimulation were examined by microarray mRNA
profiling with high-density oligonucleotide arrays using mRNA
samples prepared from control and stimulated cells. We iden-
tified 112 genes whose mRNA levels increased at least fourfold
(P 	 0.01; n 
 3) following stimulation, and 41 of them are
directly related to airway inflammation and remodeling (Table
1). In addition to these 41 genes, the mRNA levels of another
9 genes directly related to airway inflammation and remodeling
were increased two- to threefold in the stimulated cells (Table
1). These include genes coding for many key cytokines and
chemokines and genes encoding factors involved in dendritic
cell recruitment and activation, recruitment of innate immune
cells, promotion of Th2 cell polarization, or perpetuation of
epithelium changes related to asthma, fibrosis, and tissue re-
modeling. Importantly, many of these genes are also induced in
bronchial epithelium following various physiological or patho-
logical stimuli that occur during allergic inflammatory re-
sponses characteristic of asthma (29, 32). Taken together,
these observations indicate that BEAS-2B cells not only main-
tain expression of many genes directly related to airway inflam-
mation and remodeling but also respond to IL-4/TNF- treat-
ment by upregulating these genes, thereby supporting the use
of this cellular model system to study the regulation of gene
expression relevant to airway inflammation.
Stability of MCP-1 and IL-8 mRNAs is increased in acti-
vated BEAS-2B cells. To determine whether mRNA stability
may contribute to the elevation of the mRNA levels of the
mediator genes that are upregulated in activated bronchial
epithelial cells, we examined the mRNA decay of two key
chemokines in airway inflammation, MCP-1 and IL-8, in non-
stimulated and IL-4/TNF- stimulated BEAS-2B cells. We first
performed real-time RT-PCR analysis and validated that the
mRNA levels of MCP-1 and IL-8 are increased in IL-4/TNF-
-stimulated BEAS-2B cells (Fig. 1B). In contrast, the level of
the control GAPDH transcript remains similar in the cells with
or without stimulation (Fig. 1B). To determine the stability of
MCP-1 and IL-8 mRNAs, cells were treated with the transcrip-
tion inhibitor actinomycin D (ActD), and RNA samples were
extracted and analyzed at various time points. The results (Fig.
1C) show that IL-4/TNF- treatment slowed the decay of these
mRNAs. The half-lives (i.e., the time when 50% of mRNA
remained) of MCP-1 and IL-8 mRNAs increased from 3 h to
6 h and from 2.5 h to 4 h, respectively. The twofold
increase in the mRNA stability is physiologically significant
because even a moderate change in mRNA half-life can greatly
affect message levels (58). These findings, together with the
observation that eotaxin-1 mRNA is also stabilized in activated
BEAS-2B cells (2), support a critical role of mRNA turnover in
the upregulation of chemokine gene expression during airway
inflammation and remodeling.
IL-4/TNF- stimulation has little effect on the mRNA de-
stabilizing function of MCP-1 and IL-8 AREs in BEAS-2B
cells. Most cytokine and chemokine mRNAs carry AU-rich
sequences in their 3 UTRs, and decay of some of these ARE-
containing mRNAs was shown to be compromised under var-
ious immune responses; therefore, ARE-mediated mRNA de-
cay has been ascribed a key role in regulating the mRNA level
of inflammatory mediators (e.g., see reviews in references 19,
39 and 65). Since the stability of MCP-1 and IL-8 mRNAs in
BEAS-2B cells increased upon TNF-/IL-4 stimulation (Fig.
1C), we examined whether the stabilization was due to a com-
promise of the destabilizing function of their AREs. For this,
MCP-1 and IL-8 AREs (see ARE sequences in Fig. S1 in the
supplemental material) were inserted into a stable BBB
mRNA, and the decay of the reporter messages was analyzed
in BEAS-2B cells with or without IL-4/TNF- treatment. The
Tet-off promoter-driven transcriptional pulsing approach (12,
74) was used to monitor decay kinetics of BBB mRNAs car-
rying an MCP-1 or IL-8 ARE (BBBARE). A tTA-expressing
BEAS-2B-19 stable cell line that supports transcription of
genes driven by the Tet-off or Tet-on promoter (12) was trans-
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fected with plasmids encoding BBBARE mRNAs, which
were expressed under the control of an inducible Tet-off pro-
moter (26). This well-established promoter-reporter system al-
lows a transcriptional pulsing for monitoring the nearly synchro-
nous deadenylation of a uniformly sized population of mRNA
molecules, permitting evaluation of mRNA deadenylation and
decay kinetics (12, 74). The results (Fig. 2) show that both MCP-1
and IL-8 AREs have the ability to promote rapid decay of the
corresponding BBBARE mRNA in BEAS-2B cells. However,
the decay of BBBARE mRNAs did not slow down when the
cells were stimulated with IL-4/TNF- (Fig. 2), indicating that the
mRNA-destabilizing function of MCP-1 and IL-8 AREs re-
mained active after stimulation.
Protein synthesis is upregulated in activated BEAS-2B cells.
A sandwich enzyme-linked immunosorbent assay was used to
quantify the levels of MCP-1 and IL-8 proteins in cytoplasmic
lysates prepared from both nonstimulated and stimulated
BEAS-2B cells (Fig. 3). The data show that IL-4/TNF- treat-
ment elevated the production of IL-8 and MCP-1 proteins
from a nondetectable level to about 20 and 880 pg/0.5 ml of
cytoplasmic lysate, respectively, indicating that these chemo-
kines are robustly produced in activated cells. We then mea-
sured the protein synthesis rate in both nonstimulated and
stimulated BEAS-2B cells by pulse labeling nascent proteins
with [35S]methionine and cysteine. We observed a significant
increase in the global translation rate when cells were stimu-
FIG. 1. Characterizing the response of BEAS-2B cells to IL-4 and TNF- stimulation at the mRNA level and the effect of IL-4/TNF-
stimulation on mRNA stability. (A) Synergistic effect of IL-4 and TNF- on induction of MCP-1 mRNA expression in BEAS-2B cells. mRNA
levels were quantified by real-time RT-PCR. The levels of MCP-1 mRNA in cells treated with IL-4, TNF-, or both in comparison to the MCP-1
mRNA levels in cells without cytokine treatment (None; assigned a value of 1) are shown. (B) Bar graph showing that the levels of MCP-1, IL-8
mRNAs, but not the control GAPDH message are increased in IL-4/TNF- stimulated BEAS-2B cells. The levels of indicated cytoplasmic mRNAs
in either nonstimulated or IL-4/TNF--stimulated BEAS-2B cells were quantified by real-time RT-PCR and normalized to -actin mRNA
(percentage of -actin). (C) Stabilization effect of IL-4/TNF- stimulation on chemokine mRNA decay. BEAS-2B cells, either nonstimulated
(N) or stimulated (S) with IL-4/TNF- (50 ng/ml each) for 18 h, were treated with ActD (5 mg/ml) to block transcription. Cells were harvested
immediately (time zero) or after 1, 2, 4, or 6 h of ActD treatment. The levels of IL-8 and MCP-1 mRNAs were quantified by real-time RT-PCR
and normalized by the amount of GAPDH mRNA. Decay curves shown in the semilog plots were obtained by least squares analysis of the
percentage of mRNA remaining as a function of time. All data represent the mean of three experiments  standard errors.
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lated with TNF-/IL-4 (Fig. 4A). To further substantiate this
result, changes in ribosome loading onto mRNAs (polysome
profile) were determined by performing sucrose gradient frac-
tionation of cytoplasmic lysates. Comparison of the polysome
profiles from nonstimulated and stimulated cells revealed a
significant increase in the polysome fraction (Fig. 4B and C,
fractions 11 to 19) in stimulated cells, indicating that more
ribosomes are loaded on mRNAs for translation in activated
cells than in nonstimulated cells.
A major way to control translation in eukaryotes is through
altering the level of the eIF4E, a 5 cap-binding protein which
has been found to be a major target for translational control by
extracellular stimuli (25). eIF4E is the least abundant eIF and
limits formation of the translation initiation complex (16).
Thus, availability of eIF4E greatly affects the translation profile
of the cytoplasmic mRNA pool and accordingly is tightly reg-
ulated (44). We therefore checked the levels of eIF4E and
other translation regulatory factors in both nonstimulated and
stimulated cells. As shown in Fig. 4D, the level of eIF4E was
30% higher in BEAS-2B cells after stimulation with IL-4/
TNF-, whereas the level of Rck/p54, a translation repressor
(14, 71), did not change.
The availability of eIF4E for translation initiation is tightly
controlled by 4E-BPs, particularly by 4E-BP1, the most abun-
dant member of the 4E-BP family of eIF4E repressor proteins
(55). Hypophosphorylated 4E-BP1 binds and prevents eIF4E
from forming a translation initiation complex. However, eIF4E
is released from hyperphosphorylated 4E-BP1 as a result of
consecutive phosphorylation of 4E-BP1, with Ser 65 being
phosphorylated last via the phosphatidylinositol-3 kinase/Akt/
mTOR pathway (24, 44). Using antibody that specifically rec-
ognizes human 4E-BP1 proteins phosphorylated at Ser 65 (24),
we found that the level of hyperphosphorylated 4E-BP1 in-
creased about threefold upon IL-4/TNF- stimulation (Fig.
4D). This observation is fully consistent with the notion that
activation of BEAS-2B cells triggers release of eIF4E proteins
from the eIF4E/4E-BP1 complexes, making them available to
elevate translation initiation efficiency.
The levels of several other translation regulatory factors
such as eIF4G, termination release factor 1 (eRF1), and PABP
also increased in activated BEAS-2B cells (Fig. 4D). eIF4G is
a large scaffolding protein in the translation initiation complex
and is crucial for translation initiation by recruiting the 40S
ribosomal subunit, by providing a platform for 5 cap-3
poly(A) interactions on mRNA and by helping select AUG
initiation codon (53). eRF1 has been known to play a role in
enhancing efficient translation termination and also has been
suggested to play a role in promoting translation reinitiation,
thereby increasing the translation rate (33, 68). PABP en-
hances translation initiation through its interaction with eIF4G
(35, 45) and promotes translation termination through its in-
teraction with the termination complex involving eRF1 (33,
68). Thus, by coordinately upregulating the levels of key factors
necessary for translation, activated BEAS-2B cells can accom-
modate the elevated levels of mRNAs induced by IL-4/TNF-
treatment.
miRNA-mediated translational silencing is compromised in
activated BEAS-2B cells. The above findings indicate that post-
transcriptional regulation at the translation level plays an im-
portant role in sustaining high levels of production of inflam-
matory mediator proteins during inflammatory responses.
Protein production may also be elevated through mechanisms
that release translational silencing, e.g., by miRNAs, which
have emerged as important posttranscriptional regulators of
TABLE 1. mRNAs upregulated in activated BEAS-2B cells
Gene symbol(s) or
product(s)a
Fold
increase
(P 	 0.01)b
Effect(s) related to airway allergic
inflammation
CCL2 (MCP-1) 97 Chemotactic effects; recruitment
of dendritic cells and other
innate immune cells;
eosinophilia
CCL26 (Eotaxin-3) 67
CXCL1 (Gro-) 23
CXCL6 (GCP-2) 13
CXCL8 (IL-8) 242
IL-1 282 Proinflammatory and proallergic
cytokines; dendritic cell
recruitment and activation
IL-1 18
IL-6 22
IL-32 44
CSF2 (GM-CSF) 35
VEGFC 3
C3 46 Recruitment of eosinophils and
other; innate immune cellsICAM1 23
CFB 7
OLR1 6
VACM1 3
IL-4R 2 Promote Th2 cell polarization
and perpetuate epithelium
changes related to asthma;
neutrophil recruitment and
lung fibrosis
IL-17R 4
CD82 6
SLCO2A1 9
ALOX5AP 4
CD83 4
CLDN1 12 Epithelium permeability and
dendritic cell activationClaudin11 3
HBEGF 4 Tissue remodeling
COL6A1 16
COL6A2 9
Serpins (E2, E1, B8,
A3, B2)
2–37
SOD2 18
PAPPA 9
TFPI2 8
ADORA2A 8
LOX 5
CITED4 3
NFKBIA 10 Inflammation/immune response-
related transcription factorsNFKBIE 4
STAT5A 4
TNFAIP3 27 TNF--inducible proteins or
signaling proteins that
contribute to TNF- effects
BIRC3 26
PTX3 (TNFAIP5) 21
IRAK2 11
NUAK2 8
TNFAIP2 7
TNFAIP4 (Ephrin
A1)
6
TRAF1 3
a Abbreviations: GM-CSF, granulocyte-macrophage colony-stimulating factor;
VEGFC, vascular endothelial growth factor C; IL-4R, IL-4 receptor ; IL-
17R, IL-17 receptor ; SOD2, superoxide dismutase 2; HBEFG, heparin-
binding epidermal growth factor; COL6A1 and COL6A2, collagen genes; NFK-
BIA, NF-B inhibitor ; NFKBIE, NF-B inhibitor .
b Relative to cells not stimulated with IL-4/TNF-.
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gene expression (reviewed in references 21 and 34). We there-
fore examined whether the miRNA-mediated translational si-
lencing is reduced in activated BEAS-2B cells using a let-7
miRNA reporter system (54) because the let-7 miRNA family
is one of the most abundant groups of miRNAs ubiquitously
expressed in mammalian cells (63), including BEAS-2B cells.
The reporter system consists of a gene coding for the Renilla
luciferase (RL) or its derivatives RL(let-7wt), RL(let-7mut),
and RL(let-7per) in the 3 UTR (Fig. 5A). The ability of let-7
miRNA to repress translation in our cellular model was dem-
onstrated by observations that overall luciferase activity from
the RL(let-7wt) gene was dramatically lower than that from the
control RL gene in both stimulated and nonstimulated
BEAS-2B cells, whereas there was only a modest difference
FIG. 2. IL-4/TNF- stimulation has little effect on the mRNA destabilizing function of MCP-1 and IL-8 AREs in BEAS-2B cells. (A) Northern
blots showing decay of BBB mRNA (left panels), BBBARE (MCP-1) mRNA (middle panels), and BBBARE (IL-8) mRNA (right panels) in
nonstimulated (non-stimu) or in IL-4/TNF-stimulated (stimu) BEAS-2B cells. BEAS-2B-19 cells were transiently cotransfected with a Tet-off
promoter-regulated plasmid encoding a reporter mRNA as indicated and a control plasmid encoding constitutively expressed -globin/GAPDH
hybrid mRNA that serves as an internal standard for transfection efficiency and sample handling (ctrl). After 2 h of transcriptional pulse by
culturing the transfected cells in the absence of Tet, Tet (500 ng/ml) was added to block further transcription. Times correspond to hours after
transcription blockage by Tet addition. Cytoplasmic RNAs were extracted at the indicated times for Northern blot analysis. The experiments were
repeated at least once, and the results were reproducible. (B) Semilog plots showing the decay kinetics for BBB, BBBARE (MCP-1), and
BBBARE (IL-8) mRNAs. Quantification of RNA was obtained by scanning radioactive blots, as described for panel A, with an imager
(Bio-Rad).
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when RL(let-7mut) was tested (Fig. 5B). Importantly, after
IL-4/TNF- stimulation, there was a significant increase (3.5-
fold) in luciferase activity from RL(let-7wt) (Fig. 5B), indicat-
ing a reduction in translation repression of mRNA carrying
let-7 target sites. In contrast, there was only a modest increase
(1.3-fold) in the expression level of the RL, RL(let-7mut), or
RL(let-7per)gene(Fig. 5B). This modest increase is consistent
with the data showing a global increase in the translation
initiation rate in activated BEAS-2B cells (Fig. 4). Thus, our
data demonstrate that let-7 miRNA-mediated translational re-
pression is downregulated in activated airway epithelial cells.
To test the generality of the observed decrease in miRNA-
mediated mRNA silencing, we then examined the ability of two
additional miRNAs that are also found in BEAS-2B cells,
miR-155 and miR-29a, to repress translation in both IL-4/
TNF- stimulated and nonstimulated BEAS-2B cells. miR-155
regulates various immune responses in B and T cells (reviewed
in reference 57), and miR-29a is predicted to target 18 col-
lagen mRNAs (unpublished observation). Alteration of collag-
enous matrix has an important role in airway tissue remodeling
and fibrosis (e.g., see references 7 and 36). Three copies of the
target site corresponding to each miRNA were added to the
RL reporter gene to create RLmiR-155 and RLmiR-29a.
The results (Fig. 5C) show that both miRNAs repressed Re-
nilla luciferase expression in nonstimulated BEAS-2B cells,
and a consistent derepression of translation was observed in
both cases in activated BEAS-2B cells. Together, we showed
that translation silencing mediated by three different miRNAs
(let-7, miR-155, and miR-29a) is compromised in BEAS-2B
cells stimulated with IL-4 and TNF-, thereby supporting a
general reduction of miRNA-mediated translation silencing.
The number of P bodies is reduced in activated bronchial
epithelial cells, both in vitro and in vivo. P bodies are known
to be a site for storing nontranslatable mRNAs and many
mRNA decay factors in mammalian tissue culture cells. Ob-
servations of MCP-1 and IL-8 mRNA stabilization, increased
translation rate, elevated levels of factors necessary for trans-
lation, and reduced miRNA-mediated translational repression
in activated BEAS-2B cells suggest a reduction of the non-
translatable mRNA pool, which in turn may decrease the num-
ber of P bodies. To test this hypothesis, we examined P bodies
in stimulated and nonstimulated BEAS-2B cells by immuno-
fluorescence microscopy. Dcp1a, a well-characterized P-body
component required for eukaryotic mRNA decay at the de-
capping step (6, 15, 38, 43), was used as a marker to visualize
P bodies. The results show a pronounced reduction in P-body
numbers in cells treated with IL-4/TNF- (Fig. 6A). Only 10%
of stimulated cells contained 20 or more P bodies, compared
with over 54% of nonstimulated cells (Fig. 6B). Western blot
analysis showed that cytoplasmic levels of Dcp1a did not
change following IL-4/TNF- stimulation (Fig. 6C), indicating
that the loss of P bodies in activated BEAS-2B cells was not
due to a reduction of cytoplasmic Dcp1a protein.
We then analyzed P-body numbers in bronchial epithelium
in vivo using an allergen (ovalbumin)-challenged mouse model
of pulmonary inflammation (60, 76). P bodies are strikingly
abundant throughout the bronchial airway epithelium of con-
trol mice challenged with saline (Fig. 7A, left). Consistent with
our findings in BEAS-2B cells (Fig. 6), significantly fewer P
bodies were observed in the bronchial epithelium of mice with
ovalbumin-induced airway inflammation (Fig. 7A, right, and
B). The inflammatory response in ovalbumin-challenged mice
FIG. 3. Increased MCP-1 and IL-8 protein production in stimulated BEAS-2B cells. BEAS-2B cells were left untreated (nonstimulated) or
treated with IL-4/TNF- for 18 h (stimulated). Cytoplasmic lysates, prepared from equal numbers of cells, were incubated with a Human
Quantibody Inflammation array (RayBiotech, Inc.). (A) Representative images showing the results obtained using an Axon GenePix laser scanner.
POS, positive control (a biotinylated immunoglobulin G); NEG, negative control (bovine serum albumin). (B) Quantification (pg/0.5 ml) of the
data obtained from the combination of three biological and four technical repeats. Note that the y axis is on a logarithmic scale. Quantitative data
analysis was done using RayBio Q Analyzer software (RayBiotech, Inc.).
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was confirmed by demonstration of increased MCP-1 levels in
the bronchial epithelium (Fig. 7C) and by the elevated num-
bers of eosinophils in the bronchial alveolar lavage fluid
(75).
Taken together, the observations that P bodies are abundant
both in nonstimulated human bronchial epithelial BEAS-2B
cells (Fig. 6A, left) and in normal mouse bronchial epithelium
(Fig. 7A, left) and that the number of P bodies is reduced in
FIG. 4. Global translation enhancement in stimulated BEAS-2B cells. (A) BEAS-2B cells with or without IL-4/TNF- stimulation were pulse labeled with
[35S]methionine and cysteine for the indicated periods of time. Equal numbers of cells were lysed in the same volume of lysis buffer, and 50 l was used for
trichloroacetic acid precipitation and scintillation counting. Experiments were done in triplicate. (B) Polysome profiles of nonstimulated (N) and stimulated
(S) BEAS-2B cells. RNA was extracted from each of the 20 fractions, and an aliquot was used for the electrophoresis in 1% agarose to visualize the distributions
of 5.5S, 18S, and 28S rRNA bands. A representative is shown in this panel. Ctr, control. (C) The patterns showing the shift in 28S or 18S rRNA distribution
following IL-4/TNF- stimulation were separately illustrated graphically with the error bars based on the average of three independent experiments, including
the one shown in panel B. The amounts of 18S and 28S rRNAs from nonstimulated (N) and stimulated (S) cells were quantified by GeneTools (Syngene), and
band intensities were all normalized to the same range based on the band intensities exhibited by the representative profile shown in panel B. (D) Western blot
(left) showing that the levels of eIF4E, hyperphosphorylated 4E-BP1, eIF4G, eRF1, and PABP in BEAS-2B cells increased upon stimulation, whereas the level
of Rck/p54, a translation repressor, did not change. Cytoplasmic cell lysates from the same number of nonstimulated (N) and stimulated (S) cells were used.
Chemiluminescence of target bands on Western blots was captured with an imaging system (Syngene) and quantified using GeneTools (Syngene). The increase
in expression of each protein from stimulated cells in comparison to the level of the corresponding protein from nonstimulated cells (assigned a value of 11) is
shown in the bar-graph. All data represent the mean of three experiments  standard errors.
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activated bronchial epithelial cells, both in vitro and in vivo
(Fig. 6 and 7), suggest that decreased mRNA turnover, up-
regulation of translation, and the loss of P bodies are general
features of activated bronchial epithelial cells during allergic
airway inflammation.
DISCUSSION
The results of the present study shed new light on the post-
transcriptional regulation of inflammatory mediator produc-
tion at the levels of mRNA turnover and translation in
activated bronchial epithelial cells. Using a comprehensive mi-
croarray analysis of changes in mRNA expression between
nonactivated and IL-4/TNF--activated human bronchial epi-
thelial BEAS-2B cells, we found (Table 1) the following: (i)
that activated epithelial cells express high levels of mRNAs for
several cytokines and chemokines, such as IL-1-, IL-6, gran-
ulocyte-macrophage colony-stimulating factor, MCP-1, IL-8,
and exotaxin-3; (ii) expression of adhesion molecules (such as
C3, ICAM-1, and VCAM-1) that are important for recruit-
ment of innate immune cells is also greatly upregulated in
activated BEAS-2B cells; and (iii) several genes related to
airway remodeling and fibrosis are significantly upregulated in
activated cells, including genes for collagens, serine protease
inhibitors, and superoxide dismutase 2 (Table 1). It is worth
noting that mRNAs encoding five different collagens
(COL1A1, COL5A1, COL6A1, COL7A1, and COL8A1) are
rather abundant in BEAS-2B cells, suggesting a direct and
active role of bronchial epithelium in airway remodeling. Col-
lectively, these observations demonstrate that BEAS-2B cells
stimulated with IL-4/TNF- represent a useful in vitro cellular
model for investigating molecular and cellular mechanisms of
mRNA decay and translational control in airway inflammation.
Moreover, these findings support the view that bronchial epi-
thelium is a major source of many key inflammatory and re-
modeling molecules (3, 29, 31, 61) and thereby play a pivotal
role in the pathogenesis of airway diseases.
Kinetic experiments conducted in this study measuring
MCP-1 and IL-8 mRNA decay and in a previous study mea-
suring exotaxin-1 mRNA decay (2) support a critical role of
mRNA turnover in the upregulation of chemokine gene ex-
pression during airway inflammation and remodeling. Intrigu-
ingly, while the stability of mRNAs encoding two key chemo-
kines, MCP-1 and IL-8, increases in BEAS-2B cells activated
by IL-4 and TNF- (Fig. 1C), little change in the destabiliza-
tion function of their AREs was observed (Fig. 2). This finding
is of particular interest because downregulation of ARE-me-
diated mRNA decay was often considered to account for the
increased mRNA stability of an ARE-containing mediator
mRNA in response to the proinflammatory stimulation (27, 41,
66, 72, 73). Our findings that alteration of ARE-mediated
decay is not always responsible for changes in stability of an
ARE-containing message support the notion that an ARE
plays different roles in different cell types or under different
physiological conditions (5). Given the fact that RNA-destabi-
lizing elements can be anywhere in a message (e.g., 5 UTR,
protein coding region, or 3 UTRs) (10, 50), it would be inter-
esting to identify mRNA decay pathways that are involved in
the observed mRNA stabilization in activated BEAS-2B cells.
Several lines of evidence from this study demonstrate an
FIG. 5. miRNA-mediated translational repression is downregulated in activated BEAS-2B cells. (A) Schematic diagram showing the basic
Renilla luciferase reporter mRNA (RL), containing three let-7, miR-155, or miR-29a target sites (RLLet7wt, miR-155, or miR-29a), three
mutated nonfunctional let-7 target sites (RLLet7mut), or a single site that forms a perfect match with let-7 miRNAs (RLLet7per). (B and C)
Histograms representing relative changes of Renilla luciferase activity detected in extracts from nonstimulated or stimulated BEAS-2B cells
expressing the indicated RL reporter mRNA. Cells were cotransfected with a control construct expressing the firefly luciferase (FL). The RL/FL
activity detected in nonstimulated extract expressing RL mRNA was set as 1. All data represent the normalized mean of three repeats  standard
errors. ORF, open reading frame.
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enhancement of global translation rate in activated bronchial
epithelial cells. These include the following: (i) increased
[35S]methionine and cysteine incorporation into nascent
polypeptides (Fig. 4A); (ii) increased ribosomes in the poly-
some fractions (Fig. 4B and C); and (iii) increased levels of
several proteins critical for elevating translation efficiency (e.g.,
eIF4E, eRF1, and PABP) (Fig. 4D). It is worth noting that
eIF4E, which is also a 5 cap-binding protein, is the least
abundant eIF and limits formation of the translation initiation
complex (16). Moreover, eIF4E has been found to be a major
target for translational control by extracellular stimuli, such as
stress, cytokines, growth factors, and mitogens (25). Thus,
availability of eIF4E greatly affects the translation profile of
the cytoplasmic mRNA pool and is tightly regulated. As
chronic airway inflammation is often associated with wound
healing, tissue remodeling, and fibrosis, it is also worth noting
that administration of eIF4E mRNA has been shown to aug-
ment wound healing in a rat model (62). The observation that
the level of hyperphosphorylated 4E-BP1 significantly in-
creased upon IL-4/TNF- stimulation (Fig. 4D) is fully consis-
tent with the notion that activation of BEAS-2B cells triggers
release of eIF4E proteins from the eIF4E/4E-BP1 complexes,
making them available to elevate translation initiation effi-
ciency. These data reveal a new example of translational con-
trol via altering eIF4E/4E-BP1 interaction and thus provide
new insight into the mechanism by which global translation is
enhanced in activated BEAS-2B cells.
eRF1 and PABP levels were also found to increase in acti-
vated BEAS-2B cells (Fig. 4D). eRF1 associates with eRF3, a
PABP-interacting protein, to form a complex that is required
for efficient translation termination (33, 68). Recently, it was
proposed that interaction between the eRF1-eRF3 complex
and PABP/poly(A) not only enhances efficient translation ter-
mination but also promotes translation reinitiation, thereby
increasing the translation rate (33, 68). Thus, by upregulating
FIG. 6. Change in P-body numbers in BEAS-2B cells. (A) Immu-
nofluorescence microscopy showing a reduction in P-body numbers in
BEAS-2B cells treated with IL-4/TNF-. Rabbit anti-Dcp1a antibody
was used to detect P bodies (red signals). Nuclei were visualized by
DAPI staining (blue signals). The scale bar in each panel corresponds
to 15 m. (B) P-body counts of individual cells from nonstimulated or
stimulated cells (60 cells were counted for each treatment). The plot is
a merged result of at least two independent experiments. (C) Western
blot showing that the cytoplasmic level of Dcp1a did not change fol-
lowing IL-4/TNF- stimulation. GAPDH served as a loading control.
N, nonstimulated; S, stimulated.
FIG. 7. Change in P-body number in mouse activated bronchial airway epithelium. BALB/c mice were sensitized with ovalbumin, and then the
airways were challenged with either saline or ovalbumin. (A) High magnification of bronchial airways from mice challenged with saline or
ovalbumin and then subjected to immunofluorescence using rabbit anti-Dcp1a antibody to detect P bodies (red signal). Blue signal, DAPI-stained
nuclei. Scale bar, 100 m. (B) Quantification of P bodies in bronchial epithelial cells was determined by counting the number of bronchial epithelial
cells per millimeter of airway basement membrane that contained 20 or more P bodies (P-body index) using ImagePro Plus software (Media
Cybernetics). Data are presented as the mean P-body index standard error of the mean (n
 4 mice per group). The asterisk denotes a significant
difference. (C) Sections from the same mice described in panel A were stained with an antibody against MCP-1 followed by immunoperoxidase
detection (shown in brown). Scale bar, 100 m.
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the expression of factors necessary for translation, activated
BEAS-2B cells can accommodate the elevated levels of
mRNAs induced by IL-4/TNF- treatment.
Recently, miRNAs, a group of evolutionarily conserved and
abundant class of small silencing RNAs, have emerged as im-
portant posttranscriptional regulators of gene expression
across species and in multiple biological processes (21, 48, 64).
In this study, we tested three different miRNAs exhibiting
moderate to high abundance in BEAS-2B cells (data not
shown) and found that miRNA-mediated mRNA silencing is
compromised in human bronchial epithelial BEAS-2B cells
following IL-4/TNF- treatment, leading to an increase in pro-
tein levels of their targets (Fig. 5). These findings open up a
new avenue for studying mechanisms by which the modulation
of miRNA function is accomplished to help cells reset their
protein profile in response to external stimuli. One possibility
is that the increased number of translation initiation complexes
(see above) overcomes the translation initiation repression by
miRNAs (46). This interpretation is consistent with an in vitro
study showing that the addition of purified initiation complex
eIF4F, consisting of eIF4E, eIF4G, and eIF4A, to an ascites
extract rescued mRNA from miRNA-mediated translation re-
pression in vitro (46). Another intriguing possibility is that
under the physiological condition of activated BEAS-2B cells,
Ago2-miRNA complex may somehow turn into a translation
activator that promotes translation of mRNA targets. This
notion is consistent with the findings of two recent reports
showing that under specific serum-starvation conditions of
some mammalian tissue culture cells, miRNAs including
endogenous let-7 and miR-396-3 miRNAs and a synthetic
miRNA positively promote translation of reporter mRNAs
bearing the cognate miRNA target sites (69, 70).
Another important and novel finding in this study is that P
bodies, which are closely linked to mRNA decay and transla-
tion repression, are abundant both in nonstimulated human
bronchial epithelial BEAS-2B cells (Fig. 6) and in the normal
mouse bronchial epithelium (Fig. 7). Prolonged treatment of
IL-4 and TNF- caused a significant decrease of P bodies in
BEAS-2B cells (Fig. 6). A similar reduction in the P-body
population was observed in bronchial epithelium from mice
exhibiting allergic airway inflammation (Fig. 7). These findings
suggest that decreased mRNA turnover, upregulation of trans-
lation, and the loss of P bodies are general features of activated
bronchial epithelial cells during allergic airway inflammation.
It is also worth noting that the bronchial epithelium from
normal mice typically has 30 to 50 P bodies per epithelial cell
(Fig. 7A), which is much more than many cultured mammalian
cells (e.g., see references 15, 18, 22, and 51) (Fig. 6A). These
observations suggest that bronchial epithelium is primed to
elicit a response to airborne allergens or other insults by re-
leasing factors and mRNPs from P bodies to the cytoplasm,
e.g., for a boost of translation. Along this line, it is worth noting
that eIF4E, the translation initiation factor that plays a rate-
limiting role in formation of the translation initiation complex
(see above), can be stored in P bodies (1, 20). The observation
of a reduced number of P bodies in activated bronchial epi-
thelial cells raises a possibility that translation initiation is
boosted by releasing eIF4E from P bodies to the cytoplasm.
While the exact function of P bodies in mRNA turnover and
translational control remains controversial and a subject of
intensive experimentation (17, 49), our findings support a phys-
iological role of P bodies as a cellular reservoir that allows
storage and release of translation factors and dormant mRNPs
in the cytoplasm of bronchial airway epithelium. General
mRNA decay activity and translational silencing pathways may
well be active in normal bronchial epithelium to keep certain
mRNAs (e.g., those coding for inflammatory and remodeling
mediators) from being effectively translated. Upon activation
of the epithelium with inflammatory cytokines such as IL-4 and
TNF-, a concerted reduction of P bodies along with a down-
regulation of pathways that produce nontranslatable mRNPs
promotes production of mediators. To our knowledge, this
study represents the first report of a physiologically relevant
modulation of mammalian P bodies in vivo. It will be impor-
tant to determine the mechanism governing the loss of P
bodies following the stimulation of bronchial epithelial cells.
In summary, our data suggest that a combination of decreas-
ing mRNA decay, upregulating global translation, and decreas-
ing P-body abundance results in persistently elevated produc-
tion of inflammatory mediators in bronchial epithelium (Fig.
FIG. 8. Coordinated changes in mRNA turnover, translation, and RNA P bodies in bronchial epithelial cells following inflammatory stimu-
lation. Coordinate regulation of multiple posttranscriptional pathways following stimulation by proinflammatory cytokines represents a novel
mechanism that allows amplification and sustainment of protein production in bronchial epithelium during airway inflammation. See Discussion
for details.
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8). This may represent an important amplification pathway in
the regulation of inflammatory and remodeling genes in the
airway epithelium. Thus, the present study reveals a potential
new pathogenic mechanism operating at the levels of mRNA
decay and translation in bronchial epithelium to sustain the
chronic allergic inflammation and remodeling seen in allergic
airway diseases. To the best of our knowledge, this study is
among the first to demonstrate coordinate regulation of mul-
tiple posttranscriptional pathways following stimulation by fac-
tors largely thought to be activators of transcriptional path-
ways.
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